The Financial Impact of Introducing Darbepoetin Alfa (DA) as a New Long-Acting Erythropoiesis-Stimulating Agent Alternative for Non-Adherent Peritoneal Dialysis Patients in the Ministry of Health (MOH) Malaysia

Sep 1, 2018, 00:00
10.1016/j.jval.2018.07.862
https://www.valueinhealthjournal.com/article/S1098-3015(18)33219-4/fulltext
Title : The Financial Impact of Introducing Darbepoetin Alfa (DA) as a New Long-Acting Erythropoiesis-Stimulating Agent Alternative for Non-Adherent Peritoneal Dialysis Patients in the Ministry of Health (MOH) Malaysia
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33219-4&doi=10.1016/j.jval.2018.07.862
First page :
Section Title :
Open access? : No
Section Order : 92
Categories :
Tags :
Regions :
ViH Article Tags :